ProPhase Labs, Inc.
PRPH
$0.3288
-$0.0063-1.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -41.45M | -43.13M | -53.36M | -27.76M | -26.31M |
| Total Depreciation and Amortization | 6.32M | 6.53M | 6.64M | 7.58M | 6.98M |
| Total Amortization of Deferred Charges | 1.97M | 1.72M | 1.49M | 1.02M | 457.00K |
| Total Other Non-Cash Items | 7.71M | 5.73M | 12.81M | 1.54M | 1.89M |
| Change in Net Operating Assets | 14.27M | 13.37M | 14.89M | 2.85M | 1.59M |
| Cash from Operations | -11.18M | -15.78M | -17.54M | -14.77M | -15.39M |
| Capital Expenditure | -39.00K | -39.00K | -906.00K | -1.28M | -1.77M |
| Sale of Property, Plant, and Equipment | 199.00K | 282.00K | 229.00K | 229.00K | 150.00K |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 623.00K | 597.00K | 3.10M | 2.21M | 3.21M |
| Cash from Investing | 783.00K | 840.00K | 2.42M | 1.20M | 1.63M |
| Total Debt Issued | 7.18M | 7.61M | 9.86M | 8.33M | 3.87M |
| Total Debt Repaid | -5.87M | -5.57M | -4.25M | -2.50M | -888.00K |
| Issuance of Common Stock | 6.53M | 10.87M | 7.59M | 4.62M | 5.82M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 953.00K | 947.00K | 978.00K | -10.00K | -10.00K |
| Cash from Financing | 8.79M | 13.85M | 14.19M | 13.37M | 11.72M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.61M | -1.09M | -931.00K | -193.00K | -2.04M |